For the current two-month review cycle, MAP will review approximately 130 measures, about 60 of which are proposed for use in the Merit-Based Incentive Payment System (MIPS), a Centers for Medicare and Medicaid Services (CMS) program legislated by the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). This year’s list of measures under consideration covers a range of cross-cutting healthcare issues, including kidney health, prostate cancer, and heart disease. The full list of Measures Under Consideration (PDF) is available for public comment through Monday, December 7, at 6:00 pm ET.

“MAP convenes stakeholders from across the healthcare continuum to come to consensus on how to best measure quality for federal health programs,” said Christine K. Cassel, MD, president and CEO of NQF. “Their recommendations inform future CMS rulemaking focused on programs integral to improving the quality of care that patients receive.”

Established in 2011, MAP includes more than 150 healthcare leaders and experts from nearly 90 private- and public-sector organizations committed to improving healthcare quality. Stakeholders include consumers, purchasers, employers, health plans, clinicians and providers, communities and states, suppliers, and federal agency liaisons. MAP is overseen by a Coordinating Committee, with three workgroups that conduct in-depth analyses: the hospital workgroup, clinician workgroup, and post-acute and long-term care workgroup. These workgroups identify gaps in measurement across settings, prioritize measures for federal programs, and recommend areas for alignment.

MAP also provides input to HHS about core measures to assess the quality of care for children and adults covered by Medicaid, and the ten million Americans enrolled in both Medicare and Medicaid.

For more infomration, please contact measureapplications@qualityforum.org.